Prostate News Archive
06-Jan-2009
Prostate Cancer Options Abound (New London Day)
In the past year, southeastern Connecticut's two hospitals both purchased expensive new equipment employing the latest technologies to treat prostate cancer, a disease diagnosed in GTx submits NDA for toremifene to treat bone fractures in men with prostate cancer (PharmaBiz)
GTx, Inc announced the submission of a New Drug Application with the US Food and Drug Administration (FDA) for toremifene 80 mg, an oral selective estrogen receptor modulator (SERM), for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy (ADT). Prostate Health for Men (PIZZAHEROS)
If you're a man, chances are that you will eventually have some form of problem with your prostate gland. Why Prostate Cancer Patients Fail Hormone Deprivation (Medical News Today)
The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy. The findings, reported in the Jan. Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes (Medical News Today)
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar
Back to Prostate News Archive
